Literature DB >> 12570780

Why are glycoproteins modified by poly-N-acetyllactosamine glyco-conjugates?

Dapeng Zhou1.   

Abstract

Poly-N-acetyllactosamine structures occur in mammalian glycoproteins in both N- and O-linked glycans. They represent a backbone for additional modifications by fucosyltransferases, sialyltransferases and sulfotransferases. These glycans have been suggested to be involved in biospecific interactions with selectins and other glycan-binding proteins. Moreover, the poly-N-acetyllactosamine chains in N-glycans have been found to promote tumor progression and metastasis. Poly-N-acetyllactosamine chains are synthesized by repeated alternating additions of N-acetylglucosamine and galactose, catalyzed by beta-1,3-N-acetylglucosaminyltransferases (poly-N-acetyllactosamine synthase) and beta-1,4-galactosyltransferases. This review describes the poly-N-acetyllactosamine assembling machinery and focuses on recent advances in the molecular cloning and characterization of poly-N-acetyllactosamine synthase gene families. Recent progress in revealing the biological functions of poly-N-acetyllactosamine structures by various approaches in vitro and in vivo using different model systems has also been summarized.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12570780     DOI: 10.2174/1389203033380304

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  8 in total

1.  Galectin-3 expressed on different lung compartments promotes organ specific metastasis by facilitating arrest, extravasation and organ colonization via high affinity ligands on melanoma cells.

Authors:  Manohar C Dange; Nithya Srinivasan; Shyam K More; Sanjay M Bane; Archana Upadhya; Arvind D Ingle; Rajiv P Gude; Rabindranath Mukhopadhyaya; Rajiv D Kalraiya
Journal:  Clin Exp Metastasis       Date:  2014-06-21       Impact factor: 5.150

2.  Extracellular galectin-3 induces MMP9 expression by activating p38 MAPK pathway via lysosome-associated membrane protein-1 (LAMP1).

Authors:  Manohar C Dange; Akhil Kumar Agarwal; Rajiv D Kalraiya
Journal:  Mol Cell Biochem       Date:  2015-03-05       Impact factor: 3.396

Review 3.  What is the Sugar Code?

Authors:  Hans-Joachim Gabius; Maré Cudic; Tammo Diercks; Herbert Kaltner; Jürgen Kopitz; Kevin H Mayo; Paul V Murphy; Stefan Oscarson; René Roy; Andreas Schedlbauer; Stefan Toegel; Antonio Romero
Journal:  Chembiochem       Date:  2021-09-22       Impact factor: 3.461

4.  Association of beta-1,3-N-acetylglucosaminyltransferase 1 and beta-1,4-galactosyltransferase 1, trans-Golgi enzymes involved in coupled poly-N-acetyllactosamine synthesis.

Authors:  Peter L Lee; Jennifer J Kohler; Suzanne R Pfeffer
Journal:  Glycobiology       Date:  2009-03-03       Impact factor: 4.313

5.  Chemo-enzymatic modification of poly-N-acetyllactosamine (LacNAc) oligomers and N,N-diacetyllactosamine (LacDiNAc) based on galactose oxidase treatment.

Authors:  Christiane E Kupper; Ruben R Rosencrantz; Birgit Henßen; Helena Pelantová; Stephan Thönes; Anna Drozdová; Vladimir Křen; Lothar Elling
Journal:  Beilstein J Org Chem       Date:  2012-05-09       Impact factor: 2.883

6.  B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan.

Authors:  Jeremy L Praissman; David H Live; Shuo Wang; Annapoorani Ramiah; Zoeisha S Chinoy; Geert-Jan Boons; Kelley W Moremen; Lance Wells
Journal:  Elife       Date:  2014-10-03       Impact factor: 8.140

7.  Poly-LacNAc as an age-specific ligand for rotavirus P[11] in neonates and infants.

Authors:  Yang Liu; Pengwei Huang; Baoming Jiang; Ming Tan; Ardythe L Morrow; Xi Jiang
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

8.  Structural insight into the binding of human galectins to corneal keratan sulfate, its desulfated form and related saccharides.

Authors:  Michelle C Miller; Chao Cai; Kanin Wichapong; Sayantan Bhaduri; Nicola L B Pohl; Robert J Linhardt; Hans-Joachim Gabius; Kevin H Mayo
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.